{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:49:51Z","timestamp":1784807391104,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T00:00:00Z","timestamp":1495152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jaip.2017.03.003","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T12:15:54Z","timestamp":1495714554000},"page":"1402-1409.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["Randomized Trial of Icatibant for Angiotensin-Converting Enzyme Inhibitor\u2013Induced Upper Airway Angioedema"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0103-7406","authenticated-orcid":false,"given":"Richard","family":"Sinert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9089-8130","authenticated-orcid":false,"given":"Richard","family":"Body","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco L.A.","family":"Sivilotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Moellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Schranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovanna","family":"Baptista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3860-9036","authenticated-orcid":false,"given":"Alan","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Nothaft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2017.03.003_bib1","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jacc.2016.05.011","volume":"68","author":"Yancy","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaip.2017.03.003_bib2","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.2337\/dc15-S012","article-title":"Microvascular complications and foot care","volume":"38","author":"American Diabetes Association","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaip.2017.03.003_bib3","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/HYP.0000000000000003","article-title":"An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention","volume":"63","author":"Go","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.jaip.2017.03.003_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1081-1206(10)60594-7","article-title":"Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department","volume":"100","author":"Banerji","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2017.03.003_bib5","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1520\/JFS15129J","article-title":"Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease","volume":"46","author":"Dean","year":"2001","journal-title":"J\u00a0Forensic Sci"},{"key":"10.1016\/j.jaip.2017.03.003_bib6","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/archinte.165.14.1637","article-title":"Incidence and characteristics of angioedema associated with enalapril","volume":"165","author":"Kostis","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaip.2017.03.003_bib7","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/2013.jamainternmed.34","article-title":"Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system","volume":"172","author":"Toh","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaip.2017.03.003_bib8","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.1988.03410070095035","article-title":"Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition","volume":"260","author":"Slater","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2017.03.003_bib9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/clpt.2014.138","article-title":"Phenotype standardization of angioedema in the head and neck region caused by agents acting on the angiotensin system","volume":"96","author":"Wadelius","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2017.03.003_bib10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.amjmed.2014.07.011","article-title":"Angiotensin-converting enzyme inhibitor-induced angioedema","volume":"128","author":"Bezalel","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2017.03.003_bib11","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/all.12380","article-title":"Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group","volume":"69","author":"Cicardi","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.03.003_bib12","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.jaci.2013.03.034","article-title":"A\u00a0focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema","volume":"131","author":"Zuraw","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.03.003_bib13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.anai.2012.10.008","article-title":"International consensus on hereditary and acquired angioedema","volume":"109","author":"Lang","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2017.03.003_bib14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1056\/NEJMoa0906393","article-title":"Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema","volume":"363","author":"Cicardi","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2017.03.003_bib15","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJMoa1312524","article-title":"A\u00a0randomized trial of icatibant in ACE-inhibitor-induced angioedema","volume":"372","author":"Bas","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2017.03.003_bib16","doi-asserted-by":"crossref","first-page":"A28","DOI":"10.1016\/j.jval.2015.03.172","article-title":"Development and validation of the angiotensin-converting enzyme inhibitor (ACEI) induced Angioedema Investigator Rating Scale and Proposed Discharge Criteria","volume":"18","author":"Bonner","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/j.jaip.2017.03.003_bib17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/ACI.0b013e328362b835","article-title":"Angioedema induced by angiotensin-converting enzyme inhibitors","volume":"13","author":"Campo","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.03.003_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/0003489414543069","article-title":"Angiotensin converting enzyme inhibitor-related angioedema: onset, presentation, and management","volume":"124","author":"Chan","year":"2015","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jaip.2017.03.003_bib19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2332\/allergolint.12-RAI-0493","article-title":"Recent advances in drug-induced angioedema","volume":"61","author":"Inomata","year":"2012","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2017.03.003_bib20","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.iac.2006.08.001","article-title":"Angiotensin-converting enzyme inhibitor-associated angioedema","volume":"26","author":"Byrd","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2017.03.003_bib21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2340\/00015555-1760","article-title":"Angiotensin-converting enzyme inhibitor-induced angioedema\u2013a dangerous new epidemic","volume":"94","author":"Rasmussen","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2017.03.003_bib22","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1002\/lary.24777","article-title":"Risk factors associated with severe and recurrent angioedema: an epidemic linked to ACE-inhibitors","volume":"124","author":"Loftus","year":"2014","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2017.03.003_bib23","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(11)60317-6","article-title":"Effect of consent rituals on mortality in emergency care research","volume":"377","author":"Roberts","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2017.03.003_bib24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0194-5998(99)70182-8","article-title":"Predicting airway risk in angioedema: staging system based on presentation","volume":"121","author":"Ishoo","year":"1999","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2017.03.003_bib25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/acem.12341","article-title":"A\u00a0consensus parameter for the evaluation and management of angioedema in the emergency department","volume":"21","author":"Moellman","year":"2014","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jaip.2017.03.003_bib26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0091-6749(96)70151-3","article-title":"Increased sensitivity to bradykinin among African Americans","volume":"98","author":"Gainer","year":"1996","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.03.003_bib27","series-title":"Altace (ramipril) [package information]","year":"2013"},{"key":"10.1016\/j.jaip.2017.03.003_bib28","unstructured":"Caballero T, Zanichelli A, Aberer W, Maurer M, Longhurst H, Bouillet L, et\u00a0al. The effect of body mass index on icatibant treatment outcomes in patients with hereditary angioedema with C1 inhibitor deficiency: findings from the Icatibant Outcome Survey. Poster presented at: European Academy of Allergy and Clinical Immunology (EAACI) 2015 Annual Congress; June 6-10, 2015; Barcelona, Spain. Abstract\u00a0586."},{"key":"10.1016\/j.jaip.2017.03.003_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2222.2009.03323.x","article-title":"Angiotensin converting enzyme inhibitor induced angio-oedema: a review of the pathophysiology and risk factors","volume":"40","author":"Hoover","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2017.03.003_bib30","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.annemergmed.2010.03.032","article-title":"Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series","volume":"56","author":"Bas","year":"2010","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jaip.2017.03.003_bib31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.annemergmed.2014.07.014","article-title":"Ecallantide for the acute treatment of angiotensin-converting enzyme inhibitor-induced angioedema: a multicenter, randomized, controlled trial","volume":"65","author":"Lewis","year":"2015","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jaip.2017.03.003_bib32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.anai.2014.12.007","article-title":"Effectiveness of ecallantide in treating angiotensin-converting enzyme inhibitor-induced angioedema in the emergency department","volume":"114","author":"Bernstein","year":"2015","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817301721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817301721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:12:01Z","timestamp":1761973921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219817301721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S2213219817301721"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2017.03.003","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized Trial of Icatibant for Angiotensin-Converting Enzyme Inhibitor\u2013Induced Upper Airway Angioedema","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2017.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Shire HGT Inc., Richard Sinert, Phillip Levy, Jonathan A. Bernstein, Richard Body, Marco L.A. Sivilotti, and Joseph Moellman. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}